Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Base Modified Nucleotides. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103588838A reveals a novel phosphorylation method for base-modified nucleotides, offering improved selectivity and cost reduction for DNA sequencing reagent manufacturing.